Clinical application of MR spectroscopy and imaging of brain tumor

Magnetic Resonance in Medical Sciences

Volumn 9, Issue 4, 2010, Pages 167-175

  Morita, Naomi ^a,b   Harada, Masafumi ^a   Otsuka, Hideki ^a   Melhem, Elias R ^b   Nishitani, Hiromu ^a  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Advanced imaging; Brain tumor; Magnetic resonance spectroscopy; Perfusion weighted image

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ANISOTROPY; BRAIN; BRAIN TUMOR; DIFFUSION WEIGHTED IMAGING; HUMAN; IMAGE ENHANCEMENT; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; REVIEW;

ANISOTROPY; BRAIN; BRAIN NEOPLASMS; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE SPECTROSCOPY;

EID: 79955689056     PISSN: 13473182     EISSN: 18802206     Source Type: Journal    
DOI: 10.2463/mrms.9.167     Document Type: Review

References (29)

1. Al-Okaili RN, Krejza J, Wang S, Woo JH, Melhem ER. Advanced MR imaging techniques in the diagnosis of intraaxial brain tumors in adults. Radiographics 2006; 26 Suppl 1:S173-S189.
2. Al-Okaili RN, Krejza J, Woo JH, et al. Intraaxial brain masses: MR imaging-based diagnostic strategy- initial experience. Radiology 2007; 243:539-550.
3. Catalaa I, Henry R, Dillon WP, et al. Perfusion, diffusion and spectroscopy values in newly diagnosed cerebral gliomas. NMR Biomed 2006; 19: 463-475.
4. Fayed N, Daávila J, Medrano J, Olmos S. Malig-nancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol 2008; 67:427-433.
5. Aronen HJ, Gazit IE, Louis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191:41-51.
6. Young R, Babb J, Law M, Pollack E, Johnson G. Comparison of region-of-interest analysis with three different histogram analysis methods in the determination of perfusion metrics in patients with brain gliomas. J Magn Reson Imaging 2007; 26: 1053-1063.
7. Emblem KE, Nedregaard B, Nome T, et al. Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008; 247:808-817.
8. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006; 24:817-824.
9. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006; 58:394-403.
10. Law M, Yang S, Wang H, et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 2003; 24:1989-1998.
11. Law M, Young RJ, Babb JS, et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging. Radiology 2008; 247:490-498.
12. Zacharia TT, Law M, Naidich TP, Leeds NE. Central nervous system lymphoma characterization by diffusion-weighted imaging and MR spectroscopy. J Neuroimaging 2008; 18:411-417.
13. Kimura T, Sako K, Gotoh T, Tanaka K, Tanaka T. In vivo single-voxel proton MR spectroscopy in brain lesions with ring-like enhancement. NMR Biomed 2001; 14:339-349.
14. Burtscher IM, Skagerberg G, Geijer B, Englund E, Ståhlberg F, Holtås S. Proton MR spectroscopy and preoperative diagnostic accuracy: an evaluation of intracranial mass lesions characterized by stereotactic biopsy findings. AJNR Am J Neuroradiol 2000; 21:84-93.
15. Lev MH, Ozsunar Y, Henson JW, et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004; 25: 214-221 [corrected].
16. Dean BL, Drayer BP, Bird CR, et al. Gliomas: classification with MR imaging. Radiology 1990; 174:411-415.
17. Kurki T, Lundbom N, Kalimo H, Valtonen S. MR classification of brain gliomas: value of magnetization transfer and conventional imaging. Magn Reson Imaging 1995; 13:501-511.
18. Asari S, Makabe T, Katayama S, Itoh T, Tsuchida S, Ohmoto T. Assessment of the pathological grade of astrocytic gliomas using an MRI score. Neuroradiology 1994; 36:308-310.
19. Chamberlain MC, Murovic JA, Levin VA. Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas. Neurology 1988; 38:1371-1374.
20. Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (lowgrade) astrocytoma. J Neurosurg 1993; 79:533-536.
21. Perez-Cruet MJ, Adelman L, Anderson M, Roth PA, Ritter AM, Saris SC. CT-guided stereotactic biopsy of nonenhancing brain lesions. Stereotact Funct Neurosurg 1993; 61:105-117.
22. Mihara F, Numaguchi Y, Rothman M, Kristt D, Fiandaca M, Swallow L. Non-enhancing supratentorial malignant astrocytomas: MR features and possible mechanisms. Radiat Med 1995; 13:11-17.
23. Barker FG 2nd, Chang SM, Huhn SL, et al. Age and the risk of anaplasia in magnetic resonancenonenhancing supratentorial cerebral tumors. Cancer 1997; 80:936-941.
24. Scott JN, Brasher PM, Sevick RJ, Rewcastle NB, Forsyth PA. How often are nonenhancing supratentorial gliomas malignant? A population study. Neurology 2002; 59:947-949.
25. Ginsberg LE, Fuller GN, Hashmi M, Leeds NE, Schomer DF. The significance of lack of MR contrast enhancement of supratentorial brain tumors in adults: histopathological evaluation of a series. Surg Neurol 1998; 49:436-440.
26. Daumas-Duport C, Scheithauer B, O'Fallon J, Kelly P. Grading of astrocytomas. A simple and reproducible method. Cancer 1988; 62:2152-2165.
27. Burger PC, Vogel FS, Green SB, Strike TA. Glioblastoma multiforme and anaplastic astrocytoma. Pathologic criteria and prognostic implications. Cancer 1985; 56:1106-1111.
28. Burger PC. Malignant astrocytic neoplasms: classi fication, pathologic anatomy, and response to treatment. Semin Oncol 1986; 13:16-26.
29. Danchaivijitr N, Waldman AD, Tozer DJ, et al. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation? Radiology 2008; 247:170-178.